Emilia Gonzalez

Emilia (Emi) Gonzalez is a multifaceted professional with experience in venture capital, entrepreneurship, and scientific research. Here's an overview of her background and accomplishments:

Education and Early Career

Emi Gonzalez graduated from Harvard University with a Bachelor's degree in Molecular and Cellular Biology.1 During her time at Harvard, she served as the Director of the Harvard i3 Innovation Challenge, the university's premier startup competition, in 2018-2019.1 In this role, she led the organization of the $50,000 prize competition, including soliciting applications, recruiting judges, securing funding, and evaluating proposals.1

Research Experience

Gonzalez has a strong background in scientific research:

• She worked as a Research Fellow at Harvard Medical School from January 2015 to May 2018, investigating cardiac regeneration.1
• She co-authored two peer-reviewed scientific publications, including a study on exercise-induced cardiomyocyte generation published in Nature Communications.1
• She also completed a research internship at Stanford University School of Medicine in 2013.1

Entrepreneurship and Venture Capital

After her academic pursuits, Gonzalez transitioned into entrepreneurship and venture capital:

• She founded Checkmate Diabetes, a digital health platform using machine learning and behavioral psychology to motivate diabetes management.1
• She currently serves as Co-Founder and General Manager of Duckbill, an AI-powered life management service.1
• Gonzalez has held various roles in venture capital firms, including:
  • Principal at Joyance Partners and Social Starts (July 2019 - September 2021)
  • Investment Partner at Joyance Partners, Social Starts, and Ataraxia Partners (September 2021 - May 2022)
  • Venture Partner & Advisor at Joyance Partners, Social Starts, and Ataraxia Partners (May 2022 - December 2022)1

Achievements and Skills

• Gonzalez was awarded the Harvard i3 Innovation Challenge First Place in 2018.1
• She received the prestigious Hoopes Prize from Harvard University in May 2018 for outstanding scholarly work or research.1
• She is bilingual, with native or bilingual proficiency in both Spanish and English.1

Emilia Gonzalez's diverse background in scientific research, entrepreneurship, and venture capital, combined with her leadership experience at Harvard, has positioned her as a notable figure in the intersection of life sciences, biotechnology, and healthcare innovation.